Regeneus Ltd - Company & Market Research Reports

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

From
From
From
From
From
Osteoarthritis - Pipeline Review, H2 2018 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 274 Pages
From
From
From
From
From
From
From
Regeneus Ltd - Product Thumbnail Image

Regeneus Ltd

  • Company Profile
  • 73 Pages
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll